BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 8, 2018
View Archived Issues
CYT-21625 shows promising activity in models of thyroid and pancreatic neuroendocrine tumors
Read More
The flavonoid fisetin inhibits senescence and reduces age-related pathologies in elderly mice
Read More
HPV vaccination increases efficacy of PD-1 checkpoint inhibition in incurable HPV 16-related cancer
Read More
Phase I results on the combination valproate/rituximab/CHOP in diffuse large B-cell lymphoma
Read More
Safety and preliminary efficacy data from phase II study of atezolizumab plus CRT in NSCLC
Read More
The pot scrubbing the kettle: Malaria parasites could combat chikungunya symptoms
Read More
Cyclacel Pharmaceuticals forms alliance with MD Anderson Cancer Center
Read More
Patient recruitment ongoing in phase I/II study of imaging agent 89Zr-DFO-daratumumab
Read More
KINGS mouse as a novel preclinical model of diabetes
Read More
Hepato-preferential insulin analogue protects dogs from hypoglycemia
Read More
Bristol-Myers Squibb enrolling participants in phase I/II study of BMS-986310
Read More
NextCure initiates phase I/II trial of its novel antibody candidate, NC-318
Read More
First phase II results presented for LY-3298176 in patients with type 2 diabetes
Read More
Calithera Biosciences enters collaboration with Pfizer for combination studies of CB-839
Read More
Progenics reports promising phase II/III data on PyL for detection of prostate cancer
Read More
FDA approves Tegsedi to treat polyneuropathy of hATTR in adults
Read More
Revcovi approved in U.S. for ADA-SCID
Read More
Gardasil 9 approved by FDA for adults aged 27-45 years
Read More
4CMenB shows protective antibody titers 7.5 years after vaccination in adolescents and young adults
Read More
Discovery of the first nonpeptide OT-R agonist active in a mouse model of autism
Read More
UMC Utrecht Holding synthesizes modified serpins for bradykinin-mediated diseases
Read More
Two-fisted punch prevents HIV rebound
Read More
U.S. researchers divulge bacterial efflux pump inhibitors
Read More
Genentech and University of California, Oakland disclose IRE1 inhibitors
Read More